Quest Partners LLC Boosts Holdings in Integer Holdings Co. (NYSE:ITGR)

Quest Partners LLC lifted its stake in shares of Integer Holdings Co. (NYSE:ITGR) by 3,688.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 341 shares of the medical equipment provider’s stock after buying an additional 332 shares during the quarter. Quest Partners LLC’s holdings in Integer were worth $39,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Principal Securities Inc. purchased a new stake in Integer in the fourth quarter worth $67,000. Quadrant Capital Group LLC grew its position in shares of Integer by 10.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock worth $141,000 after buying an additional 132 shares during the period. Norges Bank bought a new position in shares of Integer in the 4th quarter worth about $18,697,000. Coldstream Capital Management Inc. purchased a new position in Integer during the 4th quarter valued at about $229,000. Finally, US Bancorp DE boosted its stake in Integer by 2.4% during the fourth quarter. US Bancorp DE now owns 14,837 shares of the medical equipment provider’s stock worth $1,470,000 after acquiring an additional 347 shares in the last quarter. 99.29% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Oppenheimer assumed coverage on shares of Integer in a research note on Tuesday, July 16th. They set an “outperform” rating and a $135.00 target price for the company. Benchmark reaffirmed a “buy” rating and set a $130.00 price objective on shares of Integer in a research report on Friday, August 2nd. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $133.86.

Insiders Place Their Bets

In other news, Director Jean M. Hobby sold 11,960 shares of the firm’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the sale, the director now owns 2,280 shares of the company’s stock, valued at approximately $272,824.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 2.00% of the stock is owned by insiders.

Integer Price Performance

Shares of ITGR opened at $131.48 on Friday. Integer Holdings Co. has a twelve month low of $69.40 and a twelve month high of $131.65. The company has a market capitalization of $4.41 billion, a P/E ratio of 45.49, a price-to-earnings-growth ratio of 1.81 and a beta of 1.09. The firm has a 50 day moving average of $122.80 and a 200 day moving average of $118.48. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The business had revenue of $436.20 million during the quarter, compared to analyst estimates of $437.00 million. During the same quarter last year, the company earned $1.14 EPS. The company’s quarterly revenue was up 9.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Integer Holdings Co. will post 5.31 earnings per share for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.